NuriBio

Private

AnyangHealthcare & Life Scienceshttps://nuribio.com/

Last Round

M&A

Nov 9, 2022

Est. Valuation

$21.4M

Total Funding Raised

$4.5M

Company Overview

NuriBio is a biotechnology company that develops proprietary genetic analysis tools and diagnostic kits for research and medical applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

molecular diagnosticsgenetic analysisliquid biopsyreal-time PCRqPCRmiRNA detectionctDNASNP genotypingbiomarker discoveryprecision medicinelab reagentsdiagnostic kitswet labbiotech toolscontract research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

NuriBio Comparables

Compare NuriBio with similar companies based on industry and business-model similarity.

NuriBio comparables — related companies by embedding similarity
Company	Similarity	Market Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

NuriBio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
M&A	Nov 9, 2022
VC Round	Aug 27, 2021
Series A	Jan 1, 2019
VC Round	Aug 9, 2018
Grant	Jun 1, 2018
Accelerator	Apr 17, 2018

View all Funding Rounds

Key People

Founding team and executive leadership

Young-hyean Nam

CEO

Executive Team

NuriBio Investors

Notable investors and investment history

NuriBio investors
Investor	Rounds
Seoul Business Agency	Series A
Dadam Investment	VC Round
IBK Capital	Series A
Magna Investment	VC Round

View all Investors

NuriBio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

NuriBio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about NuriBio's valuation, stock price, and market status.

Firmographic Details

HeadquartersAnyang

Employee Range1

Year Founded2014

Last FundingNov 9, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.